相关实验视频
Updated: Mar 2, 2026
10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
4.0K
介素-33增强了响应能力和巨细胞介质的释放在孤立的人类小气道
Maria Belikova1, Anna-Karin Johnsson2, Johan Kolmert3
1Unit of Integrative Metabolomics Institute of Environmental Medicine, Karolinska Institutet, Biomedicum, Quarter A7, 17165 Solna; Department of Respiratory Medicine and Allergy and Centre for Molecular Medicine, Karolinska University Hospital, SE 171 76 Solna, Sweden.
The Journal of allergy and clinical immunology
|February 28, 2026
概括
介质素-33 (IL-33) 增强了巨细胞的反应,恶化了人体呼吸道中的支气管收缩. 胸膜层淋巴蛋白 (TSLP) 和IL-25并没有影响气道的高响应性或巨细胞活性.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 细胞生物学 细胞生物学
背景情况:
- 介质蛋白 (IL) -33 ,胸膜层淋巴质蛋白 (TSLP) 和IL-25是涉及过敏呼吸道炎症的警示蛋白.
- 同时暴露于这些警示素会通过增强的巨细胞反应来增加人类小支气管中抗原诱导的收缩.
研究的目的:
- 研究IL-33,TSLP和IL-25在抗原诱导的气道过敏反应中的个别作用.
- 评估它们对超度诱导反应的影响,使用曼尼托尔作为运动诱导支气管收缩的模型.
主要方法:
- 人类的小气道段用IL-33,TSLP或IL-25进行了化.
- 对抗免疫球蛋白E (IgE) 或曼尼托尔的收缩反应使用肌肉学测量.
- 分析了乳腺细胞脱粒和媒介释放 (前列腺素D2,氨酸-氨酸) 的情况.
主要成果:
- 作为对抗IgE和曼尼托尔的反应,IL-33显著增加了收缩力.
- IL-33使得前列腺素D2的释放翻了一番,并增强了巨细胞的脱粒和介质细胞的释放.
- TSLP和IL-25对气道收缩或巨细胞反应没有显著影响.
结论:
- IL-33,但不是TSLP或IL-25,增强了人体小气道的支气管收缩.
- 这种增强是通过放大瘤细胞激活和媒介释放的介导.
- IL-33在过敏和运动诱导的气道过敏反应中发挥着关键作用.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
01:24T Cell Types and Functions
2.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
01:26Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.0K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.0K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K